Here are five things to know:
1. Wells Fargo set a “market perform” rating on Mazor stocks.
2. WallachBeth Capital lowered the price target from $21 to $16 recently.
3. Needham & Company downgraded the Mazor stock from a “buy” to a “hold” in February.
4. The stock’s market cap is $248.24 million.
5. The stock has a 50-day moving average of $11.
More articles on orthopedic devices:
Ortho Kinematics raises $9.6M in Series C equity financing
NuVasive shares’ mean target price set at $54
Long Beach Memorial 1st in region to incorporate MAKOplasty procedures
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
